Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

[Pharmacological research and pluripotent stem cells: from the innovative experimental paradigm to the successful clinical trial].

Baghdoyan S, Bassez G, Audureau E, Peschanski M.

Med Sci (Paris). 2019 Jan;35(1):26-29. doi: 10.1051/medsci/2018316. Epub 2019 Jan 23. French. No abstract available.

PMID:
30672450
2.

Pluripotent Stem Cell-Based Drug Screening Reveals Cardiac Glycosides as Modulators of Myotonic Dystrophy Type 1.

Maury Y, Poydenot P, Brinon B, Lesueur L, Gide J, Roquevière S, Côme J, Polvèche H, Auboeuf D, Alexandre Denis J, Pietu G, Furling D, Lechuga M, Baghdoyan S, Peschanski M, Martinat C.

iScience. 2019 Jan 25;11:258-271. doi: 10.1016/j.isci.2018.12.019. Epub 2018 Dec 27.

3.

[The time has come of a therapeutic (re)positioning of the ultra-rare diseases].

Martinat C, Peschanski M.

Med Sci (Paris). 2018 Dec;34(12):1019-1021. doi: 10.1051/medsci/2018302. Epub 2019 Jan 9. French. No abstract available.

PMID:
30623755
4.

Reply: Could weight loss contribute to the improved mobility with metformin in patients with myotonic dystrophy type 1?

Bassez G, Audureau E, Peschanski M.

Brain. 2019 Feb 1;142(2):e6. doi: 10.1093/brain/awy337. No abstract available.

PMID:
30615109
5.

Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial.

Bassez G, Audureau E, Hogrel JY, Arrouasse R, Baghdoyan S, Bhugaloo H, Gourlay-Chu ML, Le Corvoisier P, Peschanski M.

Brain. 2018 Oct 1;141(10):2855-2865. doi: 10.1093/brain/awy231.

PMID:
30169600
6.

Human ESC-derived retinal epithelial cell sheets potentiate rescue of photoreceptor cell loss in rats with retinal degeneration.

Ben M'Barek K, Habeler W, Plancheron A, Jarraya M, Regent F, Terray A, Yang Y, Chatrousse L, Domingues S, Masson Y, Sahel JA, Peschanski M, Goureau O, Monville C.

Sci Transl Med. 2017 Dec 20;9(421). pii: eaai7471. doi: 10.1126/scitranslmed.aai7471.

PMID:
29263231
7.

Differentiation of nonhuman primate pluripotent stem cells into functional keratinocytes.

Domingues S, Masson Y, Marteyn A, Allouche J, Perrier AL, Peschanski M, Martinat C, Baldeschi C, Lemaître G.

Stem Cell Res Ther. 2017 Dec 19;8(1):285. doi: 10.1186/s13287-017-0741-9.

8.

Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells.

Egesipe AL, Blondel S, Cicero AL, Jaskowiak AL, Navarro C, Sandre-Giovannoli A, Levy N, Peschanski M, Nissan X.

NPJ Aging Mech Dis. 2016 Nov 10;2:16026. doi: 10.1038/npjamd.2016.26. eCollection 2016.

9.

Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort study.

Senet P, Blas-Chatelain C, Levy P, Manea EM, Peschanski M, Mirault T, Stankovic-Stojanovic K, Debure C, Debbache K, Girot R, Bureau JM, Bachmeyer C, Baldeschi C, Galacteros F, Lionnet F, Gellen-Dautremer J.

Br J Dermatol. 2017 Jul;177(1):206-211. doi: 10.1111/bjd.15241. Epub 2017 Apr 26.

PMID:
27992062
10.

Impedimetric real-time monitoring of neural pluripotent stem cell differentiation process on microelectrode arrays.

Seidel D, Obendorf J, Englich B, Jahnke HG, Semkova V, Haupt S, Girard M, Peschanski M, Brüstle O, Robitzki AA.

Biosens Bioelectron. 2016 Dec 15;86:277-286. doi: 10.1016/j.bios.2016.06.056. Epub 2016 Jun 20.

11.

Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome.

Darville H, Poulet A, Rodet-Amsellem F, Chatrousse L, Pernelle J, Boissart C, Héron D, Nava C, Perrier A, Jarrige M, Cogé F, Millan MJ, Bourgeron T, Peschanski M, Delorme R, Benchoua A.

EBioMedicine. 2016 Jul;9:293-305. doi: 10.1016/j.ebiom.2016.05.032. Epub 2016 May 27.

12.

PPARγ Is Activated during Congenital Cytomegalovirus Infection and Inhibits Neuronogenesis from Human Neural Stem Cells.

Rolland M, Li X, Sellier Y, Martin H, Perez-Berezo T, Rauwel B, Benchoua A, Bessières B, Aziza J, Cenac N, Luo M, Casper C, Peschanski M, Gonzalez-Dunia D, Leruez-Ville M, Davrinche C, Chavanas S.

PLoS Pathog. 2016 Apr 14;12(4):e1005547. doi: 10.1371/journal.ppat.1005547. eCollection 2016 Apr.

13.

Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylation.

Blondel S, Egesipe AL, Picardi P, Jaskowiak AL, Notarnicola M, Ragot J, Tournois J, Le Corf A, Brinon B, Poydenot P, Georges P, Navarro C, Pitrez PR, Ferreira L, Bollot G, Bauvais C, Laustriat D, Mejat A, De Sandre-Giovannoli A, Levy N, Bifulco M, Peschanski M, Nissan X.

Cell Death Dis. 2016 Feb 18;7:e2105. doi: 10.1038/cddis.2015.374.

14.

Dp412e: a novel human embryonic dystrophin isoform induced by BMP4 in early differentiated cells.

Massouridès E, Polentes J, Mangeot PE, Mournetas V, Nectoux J, Deburgrave N, Nusbaum P, Leturcq F, Popplewell L, Dickson G, Wein N, Flanigan KM, Peschanski M, Chelly J, Pinset C.

Skelet Muscle. 2015 Nov 14;5:40. doi: 10.1186/s13395-015-0062-6. eCollection 2015.

15.

In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin.

Laustriat D, Gide J, Barrault L, Chautard E, Benoit C, Auboeuf D, Boland A, Battail C, Artiguenave F, Deleuze JF, Bénit P, Rustin P, Franc S, Charpentier G, Furling D, Bassez G, Nissan X, Martinat C, Peschanski M, Baghdoyan S.

Mol Ther Nucleic Acids. 2015 Nov 3;4:e262. doi: 10.1038/mtna.2015.35.

16.

Protein Kinase-A Inhibition Is Sufficient to Support Human Neural Stem Cells Self-Renewal.

Georges P, Boissart C, Poulet A, Peschanski M, Benchoua A.

Stem Cells. 2015 Dec;33(12):3666-72. doi: 10.1002/stem.2194. Epub 2015 Sep 16.

17.

Cytostatic Effect of Repeated Exposure to Simvastatin: A Mechanism for Chronic Myotoxicity Revealed by the Use of Mesodermal Progenitors Derived from Human Pluripotent Stem Cells.

Peric D, Barragan I, Giraud-Triboult K, Egesipe AL, Meyniel-Schicklin L, Cousin C, Lotteau V, Petit V, Touhami J, Battini JL, Sitbon M, Pinset C, Ingelman-Sundberg M, Laustriat D, Peschanski M.

Stem Cells. 2015 Oct;33(10):2936-48. doi: 10.1002/stem.2107. Epub 2015 Aug 6.

18.

In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells.

Allouche J, Bellon N, Saidani M, Stanchina-Chatrousse L, Masson Y, Patwardhan A, Gilles-Marsens F, Delevoye C, Domingues S, Nissan X, Martinat C, Lemaitre G, Peschanski M, Baldeschi C.

Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):9034-9. doi: 10.1073/pnas.1501032112. Epub 2015 Jul 6.

19.

[The 2000 years].

Peschanski M, Bergeron M, Boué A, Coppens Y, Changeux JP, Corvol P, Lazar P, Kahn A, Bichet DG, Friedlander G, Epelbaum J, Kroemer G, Chneiweiss H, Munnich A, Bouvier M, Jordan B, Frydman R, Morange M, Fougereau M.

Med Sci (Paris). 2015 Mar;31 Spec No 1:47-90. doi: 10.1051/medsci/201531s1005. Epub 2015 Jun 3. French. No abstract available.

20.

[The 1990 years].

Kahn A, Bergeron M, Gros F, Lhoste JM, Peschanski M, Glorieux FH, Gilgenkrantz S.

Med Sci (Paris). 2015 Mar;31 Spec No 1:27-46. doi: 10.1051/medsci/201531s1004. Epub 2015 Jun 3. French. No abstract available.

21.

Development of a global network of induced pluripotent stem cell haplobanks.

Wilmut I, Leslie S, Martin NG, Peschanski M, Rao M, Trounson A, Turner D, Turner ML, Yamanaka S, Taylor CJ.

Regen Med. 2015;10(3):235-8. doi: 10.2217/rme.15.1. No abstract available.

PMID:
25933231
22.

Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).

Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brüstle O, Choi M, Choi YM, Crook JM, de Sousa PA, Dvorak P, Freund C, Firpo M, Furue MK, Gokhale P, Ha HY, Han E, Haupt S, Healy L, Hei DJ, Hovatta O, Hunt C, Hwang SM, Inamdar MS, Isasi RM, Jaconi M, Jekerle V, Kamthorn P, Kibbey MC, Knezevic I, Knowles BB, Koo SK, Laabi Y, Leopoldo L, Liu P, Lomax GP, Loring JF, Ludwig TE, Montgomery K, Mummery C, Nagy A, Nakamura Y, Nakatsuji N, Oh S, Oh SK, Otonkoski T, Pera M, Peschanski M, Pranke P, Rajala KM, Rao M, Ruttachuk R, Reubinoff B, Ricco L, Rooke H, Sipp D, Stacey GN, Suemori H, Takahashi TA, Takada K, Talib S, Tannenbaum S, Yuan BZ, Zeng F, Zhou Q.

Regen Med. 2015;10(2 Suppl):1-44. doi: 10.2217/rme.14.93. No abstract available.

PMID:
25675265
23.

Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes.

Maury Y, Côme J, Piskorowski RA, Salah-Mohellibi N, Chevaleyre V, Peschanski M, Martinat C, Nedelec S.

Nat Biotechnol. 2015 Jan;33(1):89-96. doi: 10.1038/nbt.3049. Epub 2014 Nov 10.

PMID:
25383599
24.

The SEURAT-1 approach towards animal free human safety assessment.

Gocht T, Berggren E, Ahr HJ, Cotgreave I, Cronin MT, Daston G, Hardy B, Heinzle E, Hescheler J, Knight DJ, Mahony C, Peschanski M, Schwarz M, Thomas RS, Verfaillie C, White A, Whelan M.

ALTEX. 2015;32(1):9-24. doi: 10.14573/altex.1408041. Epub 2014 Nov 5.

25.

Induced pluripotent stem cells reveal functional differences between drugs currently investigated in patients with hutchinson-gilford progeria syndrome.

Blondel S, Jaskowiak AL, Egesipe AL, Le Corf A, Navarro C, Cordette V, Martinat C, Laabi Y, Djabali K, de Sandre-Giovannoli A, Levy N, Peschanski M, Nissan X.

Stem Cells Transl Med. 2014 Apr;3(4):510-9. doi: 10.5966/sctm.2013-0168. Epub 2014 Mar 5.

26.

Toward the development of a global induced pluripotent stem cell library.

Turner M, Leslie S, Martin NG, Peschanski M, Rao M, Taylor CJ, Trounson A, Turner D, Yamanaka S, Wilmut I.

Cell Stem Cell. 2013 Oct 3;13(4):382-4. doi: 10.1016/j.stem.2013.08.003.

27.

Pluripotent stem cells as a model to study non-coding RNAs function in human neurogenesis.

Benchoua A, Peschanski M.

Front Cell Neurosci. 2013 Aug 27;7:140. doi: 10.3389/fncel.2013.00140. eCollection 2013.

28.

Differentiation from human pluripotent stem cells of cortical neurons of the superficial layers amenable to psychiatric disease modeling and high-throughput drug screening.

Boissart C, Poulet A, Georges P, Darville H, Julita E, Delorme R, Bourgeron T, Peschanski M, Benchoua A.

Transl Psychiatry. 2013 Aug 20;3:e294. doi: 10.1038/tp.2013.71.

29.

A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1.

Gauthier M, Marteyn A, Denis JA, Cailleret M, Giraud-Triboult K, Aubert S, Lecuyer C, Marie J, Furling D, Vernet R, Yanguas C, Baldeschi C, Pietu G, Peschanski M, Martinat C.

Hum Mol Genet. 2013 Dec 20;22(25):5188-98. doi: 10.1093/hmg/ddt373. Epub 2013 Aug 6.

PMID:
23922231
30.

Embryonic stem cells neural differentiation qualifies the role of Wnt/β-Catenin signals in human telencephalic specification and regionalization.

Nicoleau C, Varela C, Bonnefond C, Maury Y, Bugi A, Aubry L, Viegas P, Bourgois-Rocha F, Peschanski M, Perrier AL.

Stem Cells. 2013 Sep;31(9):1763-74. doi: 10.1002/stem.1462.

31.

High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes.

Charbord J, Poydenot P, Bonnefond C, Feyeux M, Casagrande F, Brinon B, Francelle L, Aurégan G, Guillermier M, Cailleret M, Viegas P, Nicoleau C, Martinat C, Brouillet E, Cattaneo E, Peschanski M, Lechuga M, Perrier AL.

Stem Cells. 2013 Sep;31(9):1816-28. doi: 10.1002/stem.1430.

32.

Genetically-modified human pluripotent stem cells: new hopes for the understanding and the treatment of neurological diseases?

Nedelec S, Onteniente B, Peschanski M, Martinat C.

Curr Gene Ther. 2013 Apr;13(2):111-9. Review.

PMID:
23444870
33.

mTOR-dependent proliferation defect in human ES-derived neural stem cells affected by myotonic dystrophy type 1.

Denis JA, Gauthier M, Rachdi L, Aubert S, Giraud-Triboult K, Poydenot P, Benchoua A, Champon B, Maury Y, Baldeschi C, Scharfmann R, Piétu G, Peschanski M, Martinat C.

J Cell Sci. 2013 Apr 15;126(Pt 8):1763-72. doi: 10.1242/jcs.116285. Epub 2013 Feb 26.

34.

How can human pluripotent stem cells help decipher and cure Huntington's disease?

Perrier A, Peschanski M.

Cell Stem Cell. 2012 Aug 3;11(2):153-61. doi: 10.1016/j.stem.2012.07.015.

35.

Unique preservation of neural cells in Hutchinson- Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA.

Nissan X, Blondel S, Navarro C, Maury Y, Denis C, Girard M, Martinat C, De Sandre-Giovannoli A, Levy N, Peschanski M.

Cell Rep. 2012 Jul 26;2(1):1-9. doi: 10.1016/j.celrep.2012.05.015. Epub 2012 Jun 21.

36.

[miR-9: the sentinel of neurons in progeria].

Blondel S, Navarro C, Lévy N, Peschanski M, Nissan X.

Med Sci (Paris). 2012 Jun-Jul;28(6-7):663-6. doi: 10.1051/medsci/2012286022. Epub 2012 Jul 16. Review. French. No abstract available.

37.

Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells.

Feyeux M, Bourgois-Rocha F, Redfern A, Giles P, Lefort N, Aubert S, Bonnefond C, Bugi A, Ruiz M, Deglon N, Jones L, Peschanski M, Allen ND, Perrier AL.

Hum Mol Genet. 2012 Sep 1;21(17):3883-95. doi: 10.1093/hmg/dds216. Epub 2012 Jun 7.

PMID:
22678061
38.

[Jumping translocations of chromosome 1q are recurring chromosomal -aberrations in neural derivatives of pluripotent stem cells].

Varela C, Denis JA, Peschanski M, Lefort N.

Med Sci (Paris). 2012 Feb;28(2):219-21. doi: 10.1051/medsci/2012282023. Epub 2012 Feb 27. Review. French. No abstract available.

39.

miR-125 potentiates early neural specification of human embryonic stem cells.

Boissart C, Nissan X, Giraud-Triboult K, Peschanski M, Benchoua A.

Development. 2012 Apr;139(7):1247-57. doi: 10.1242/dev.073627. Epub 2012 Feb 22.

40.

Recurrent genomic instability of chromosome 1q in neural derivatives of human embryonic stem cells.

Varela C, Denis JA, Polentes J, Feyeux M, Aubert S, Champon B, Piétu G, Peschanski M, Lefort N.

J Clin Invest. 2012 Feb;122(2):569-74. doi: 10.1172/JCI46268. Epub 2012 Jan 24.

41.

[Melanocytes derived from pluripotent stem cells: a new biological resource for pigmentary disorders].

Nissan X, Lemaitre G, Peschanski M, Baldeschi C.

Med Sci (Paris). 2011 Nov;27(11):935-8. doi: 10.1051/medsci/20112711007. Epub 2011 Nov 30. French. No abstract available.

42.

In vitro pathological modelling using patient-specific induced pluripotent stem cells: the case of progeria.

Nissan X, Blondel S, Peschanski M.

Biochem Soc Trans. 2011 Dec;39(6):1775-9. doi: 10.1042/BST20110659. Review.

PMID:
22103524
43.

Coloring skin with pluripotent stem cells.

Nissan X, Lemaitre G, Peschanski M, Baldeschi C.

Cell Cycle. 2011 Dec 1;10(23):3985-6. doi: 10.4161/cc.10.23.18249. Epub 2011 Dec 1. Review. No abstract available.

PMID:
22101274
44.

The role of human leukocyte antigen matching in the development of multiethnic "haplobank" of induced pluripotent stem cell lines.

Gourraud PA, Gilson L, Girard M, Peschanski M.

Stem Cells. 2012 Feb;30(2):180-6. doi: 10.1002/stem.772.

45.

Human pluripotent stem cells for disease modelling and drug screening.

Maury Y, Gauthier M, Peschanski M, Martinat C.

Bioessays. 2012 Jan;34(1):61-71. doi: 10.1002/bies.201100071. Epub 2011 Oct 28. Review.

PMID:
22038777
47.

Human pluripotent stem cells for genetic disease modeling and drug screening.

Gauthier M, Maury Y, Peschanski M, Martinat C.

Regen Med. 2011 Sep;6(5):607-22. doi: 10.2217/rme.11.46. Review.

PMID:
21916596
48.

Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis.

Nissan X, Larribere L, Saidani M, Hurbain I, Delevoye C, Feteira J, Lemaitre G, Peschanski M, Baldeschi C.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14861-6. doi: 10.1073/pnas.1019070108. Epub 2011 Aug 19. Erratum in: Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17856.

49.

Protein transfer into human cells by VSV-G-induced nanovesicles.

Mangeot PE, Dollet S, Girard M, Ciancia C, Joly S, Peschanski M, Lotteau V.

Mol Ther. 2011 Sep;19(9):1656-66. doi: 10.1038/mt.2011.138. Epub 2011 Jul 12.

50.

miR-203 modulates epithelial differentiation of human embryonic stem cells towards epidermal stratification.

Nissan X, Denis JA, Saidani M, Lemaitre G, Peschanski M, Baldeschi C.

Dev Biol. 2011 Aug 15;356(2):506-15. doi: 10.1016/j.ydbio.2011.06.004. Epub 2011 Jun 12.

Supplemental Content

Loading ...
Support Center